Pricing Log in Create free account

Champions Oncology, Inc. (CSBR) vs MediciNova, Inc. (MNOV)

Champions Oncology, Inc. and MediciNova, Inc. are both Biotechnology companies. Champions Oncology, Inc. and MediciNova, Inc. are of similar size ($71.4M and $66.3M). Champions Oncology, Inc. grew revenue faster over the last twelve months: 6.65% against −82.2%. Champions Oncology, Inc. has the higher net margin (−1.87% vs −1,168.3%) and the lower return on invested capital (−626.2% vs −62.5%). Across the 16 metrics below, Champions Oncology, Inc. leads on 11 and MediciNova, Inc. on 5.

Valuation

Metric CSBR MNOV Biotechnology median
P/E n/m n/m 10.60
P/S 1.10 78.08 9.40
P/B 14.96 1.93 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 200.80 n/m 0.66
EV/Sales 1.03 50.46 9.02
Earnings yield (1.67%) (14.38%) (32.88%)
Free cash flow yield (9.16%) (12.70%) (23.13%)

Profitability

Metric CSBR MNOV Biotechnology median
Gross margin 49.82% 37.76% 68.51%
Operating margin (1.68%) (1,287.53%) 0.00%
Net margin (1.87%) (1,168.31%) 0.00%
Free cash flow margin (10.08%) (991.31%) 0.00%
Return on equity (28.38%) (25.56%) (51.96%)
Return on assets (3.56%) (23.83%) (46.06%)
Return on invested capital (626.23%) (62.48%) 0.00%

Growth

Metric CSBR MNOV Biotechnology median
Revenue growth (TTM) 6.65% (82.20%) 6.76%
EPS growth (last fiscal year) (124.24%) (4.35%) 29.88%
Revenue growth, 5-year CAGR 7.68% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CSBR MNOV Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.03 8.75 4.97
Net debt to EBITDA (20.56) 2.32 1.01

Dividend

Metric CSBR MNOV Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CSBR MNOV Biotechnology median
Market cap 66.26m 71.37m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack